Why the Epidermal Growth Factor Receptor? The Rationale for Cancer Therapy

Why the Epidermal Growth Factor Receptor? The Rationale for Cancer Therapy José Baselga Oncologist 2002; 7(Suppl 4): 2-8 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of cancer medicine in clinical pharmacology and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Explain the molecular biology of epidermal growth factor receptor (EGFR) function in malignant cells. Recognize the relationships between and functions of the erbB family of related cell membrane receptors. Describe the current status of clinical strategies to inhibit EGFR function in malignant cells. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Aug. 28, 2002 Most Recent Review: June 10, 2005* Most Recent Update: Aug. 28, 2002 Date Credit Expires: Apr. 10, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.

Click Here to return to the complete course listing of ZD1839 (Iressa™): A New Targeted Therapy for Solid Tumors